Cargando…

Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome

Myelodysplastic syndromes (MDS) are hematological malignancies of unclear etiology where oxidative stress may contribute to the pathogenesis. Methylarginines, naturally occurring inhibitors of NO synthase, can increase superoxide generation from uncoupled NO synthase. We found significant increase i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Štikarová, Jana, Suttnar, Jiří, Pimková, Kristýna, Chrastinová-Mášová, Leona, Čermák, Jaroslav, Dyr, Jan E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765587/ https://www.ncbi.nlm.nih.gov/pubmed/23958336 http://dx.doi.org/10.1186/1756-8722-6-58

Ejemplares similares

Plasma Levels of Aminothiols, Nitrite, Nitrate, and Malondialdehyde in Myelodysplastic Syndromes in the Context of Clinical Outcomes and as a Consequence of Iron Overload
por: Pimková, Kristýna, et al.
Publicado: (2014)

A New Approach for the Diagnosis of Myelodysplastic Syndrome Subtypes Based on Protein Interaction Analysis
por: Chrastinová, Leona, et al.
Publicado: (2019)

The Effect of Reagents Mimicking Oxidative Stress on Fibrinogen Function
por: Štikarová, Jana, et al.
Publicado: (2013)

Fibrin Clot Formation under Oxidative Stress Conditions
por: Kaufmanova, Jirina, et al.
Publicado: (2021)

Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome
por: Májek, Pavel, et al.
Publicado: (2012)

Proteome Changes in the Plasma of Myelodysplastic Syndrome Patients with Refractory Anemia with Excess Blasts Subtype 2
por: Majek, Pavel, et al.
Publicado: (2014)

Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome
por: Májek, Pavel, et al.
Publicado: (2013)

Linking aberrant glycosylation of plasma glycoproteins with progression of myelodysplastic syndromes: a study based on plasmonic biosensor and lectin array
por: Chrastinová, Leona, et al.
Publicado: (2023)

Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients
por: Pecankova, Klara, et al.
Publicado: (2017)

Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin
por: Májek, Pavel, et al.
Publicado: (2010)

Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia
por: Májek, Pavel, et al.
Publicado: (2011)

Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups
por: Majek, Pavel, et al.
Publicado: (2015)

Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome
por: Pecankova, Klara, et al.
Publicado: (2015)

Impact of posttranslational modifications on atomistic structure of fibrinogen
por: Sovová, Žofie, et al.
Publicado: (2020)

Obituary for Professor Dr. Jan Evangelista Dyr
por: Mášová-Chrastinová, Leona, et al.
Publicado: (2021)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

Serum Asymmetric Dimethylarginine Levels in Patients with Vasovagal Syncope
por: Atıcı, Adem, et al.
Publicado: (2019)

Molecular Dynamic Simulations Suggest That Metabolite-Induced Post-Translational Modifications Alter the Behavior of the Fibrinogen Coiled-Coil Domain
por: Sovova, Zofie, et al.
Publicado: (2021)

Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)

Diabetic Retinopathy Is Associated With Elevated Serum Asymmetric and Symmetric Dimethylarginines
por: Abhary, Sotoodeh, et al.
Publicado: (2009)

Helicobacter pylori Eradication Lowers Serum Asymmetric Dimethylarginine Levels
por: Aydemir, Selim, et al.
Publicado: (2010)

Structural and Functional Characterization of Four Novel Fibrinogen Mutations in FGB Causing Congenital Fibrinogen Disorder
por: Ceznerová, Eliška, et al.
Publicado: (2022)

Risk of Cardiovascular Diseases in Diabetes Mellitus and Serum Concentration of Asymmetrical Dimethylarginine
por: Jawalekar, Seema L., et al.
Publicado: (2013)

The relationship between serum asymmetric dimethylarginine levels and radial artery spasm
por: Kocayiğit, İbrahim, et al.
Publicado: (2020)

Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013)

Renal asymmetric dimethylarginine inhibits fibrosis
por: Wu, Ming, et al.
Publicado: (2020)

Association Between Serum Levels of Carotenoids and Serum Asymmetric Dimethylarginine Levels in Japanese Subjects
por: Watarai, Rika, et al.
Publicado: (2014)

Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis
por: Ikenaka, Kensuke, et al.
Publicado: (2022)

Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
por: Aldámiz-Echevarría, Luis, et al.
Publicado: (2012)

Arginine/Asymmetric Dimethylarginine Ratio in Colorectal Surgery
por: Ragina, Neli, et al.
Publicado: (2017)

Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
por: Xie, Ziang, et al.
Publicado: (2022)

L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis
por: Pascale, Valerio, et al.
Publicado: (2013)

Increased symmetric dimethylarginine, but not asymmetric dimethylarginine, concentrations are associated with transient myocardial ischemia and predict outcome
por: Szabo, Zsuzsanna, et al.
Publicado: (2020)

Serum concentrations of asymmetric and symmetric dimethylarginine are associated with mortality in acute heart failure patients
por: Potočnjak, Ines, et al.
Publicado: (2018)

Effect of Blood Component Coatings of Enosseal Implants on Proliferation and Synthetic Activity of Human Osteoblasts and Cytokine Production of Peripheral Blood Mononuclear Cells
por: Himmlova, Lucie, et al.
Publicado: (2016)

Resolution and quantification of arginine, monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma using HPLC with internal calibration
por: Alkaitis, Matthew S., et al.
Publicado: (2015)

Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
por: Lee, Tzong-Shyuan, et al.
Publicado: (2021)

Live and let die: asymmetric dimethylarginine and septic shock
por: Böger, Rainer H
Publicado: (2006)

Mechanism of Cellular Oxidation Stress Induced by Asymmetric Dimethylarginine
por: Mohan, Srinidi, et al.
Publicado: (2012)

Asymmetric Dimethylarginine (ADMA) and Endothelial Dysfunction: Implications for Atherogenesis
por: Landim, Maurício Batista Paes, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2ia3rth59u4v2lcjsveb5mp4of